July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Long-term Outcomes of Mitomycin C Trabeculectomy for Exfoliative Glaucoma in Phakic Eyes versus Pseudophakic Eyes
Author Affiliations & Notes
  • Sooncheol Cha
    Ophthalmology, Yeungnam Univ. Hospital, Daegu, Korea (the Democratic People's Republic of)
  • Cheolwon Moon
    Ophthalmology, Yeungnam Univ. Hospital, Daegu, Korea (the Democratic People's Republic of)
  • Wonmo Gu
    Ophthalmology, Yeungnam Univ. Hospital, Daegu, Korea (the Democratic People's Republic of)
  • Junhyuk Son
    Ophthalmology, Yeungnam Univ. Hospital, Daegu, Korea (the Democratic People's Republic of)
  • Footnotes
    Commercial Relationships   Sooncheol Cha, None; Cheolwon Moon, None; Wonmo Gu, None; Junhyuk Son, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6633. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sooncheol Cha, Cheolwon Moon, Wonmo Gu, Junhyuk Son; Long-term Outcomes of Mitomycin C Trabeculectomy for Exfoliative Glaucoma in Phakic Eyes versus Pseudophakic Eyes. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6633.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The successful long-term management of exfoliative glaucoma (XFG) patients with cataract remains a clinical challenge. One prospective study reported the ocular hypotensive effect of phacoemulsification was greater in patients with exfoliation syndrome (XFS) compared to control patients without XFS, in particular more pronounced in patients with XFG. The objective of this study is to determine whether previous modern phacoemulsification surgery affects surgical prognosis of primary trabeculectomy with MMC for XFG.

Methods : This retrospective, consecutive study included 51 phakic eyes and 40 pseudophakic eyes (that had previously undergone phacoemulsification with temporal clear cornea incision) of XFG undergoing primary trabeculectomy with MMC. Surgical success was defined by intraocular pressure (IOP) < 18mm Hg and IOP reduction ≥ 20% with or without medication. Cumulative probabilities of success were compared using Kaplan-Meier survival analysis, and risk factors of surgical failure were analyzed with the Cox proportional hazards model.

Results : The mean follow-up period was 44.7 ± 28.0 months. IOP decreased by 4.5 mm Hg in phakic eyes versus 11.1 mm Hg in pseudophakic eyes at last visits after surgery (p=0.005). Cumulative success rates were 78.4% at 1 year and 15.0% at 5 years for phakic eyes, and 85.0% and 31.5%, respectively, for pseudophakic eyes by complete success. Complete success rates were tended to be higher for pseudophakic eyes than for phakic eyes (p=0.068). Qualified success did not show a statistically significant difference (p=0.553). The risk factors associated with surgical failure were early postoperative hypotony (hazard ratio=2.81, p=0.016, complete success) and phakic status (hazard ratio=1.97, p=0.040, complete success).

Conclusions : Long-term outcomes of primary trabeculectomy with MMC for XFG in eyes with prior phacoemulsification are comparable to or even better than those in phakic eyes. The later performing cataract surgery in previous trabeculectomized eyes seems to have had adversely effects on long-term outcomes of primary trabeculectomy. Therefore, this study suggests that performing phacoemulsification first and later trabeculectomy may be a better option if trabeculectomy is required on XFG patients with cataract.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×